📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. (2021)

First Author: Datoo MS

Attributed to: Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00943-0

PubMed Identifier: 33964223

Publication URI: http://europepmc.org/abstract/MED/33964223

Type: Journal Article/Review

Volume: 397

Parent Publication: Lancet (London, England)

Issue: 10287

ISSN: 0140-6736